<HTML>
<HEAD>
<TITLE>sv8</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<P align="center" style="font-size: 10pt"><B>As filed with the
Securities and Exchange Commission on August 4, 2004</B>



<P align="right" style="font-size: 10pt"><B>Registration No.&nbsp;333-</B>



<HR size="4" noshade color="#000000" style="margin-top: -5px">
<HR size="1" noshade color="#000000" style="margin-top: -10px">





<DIV align="center" style="font-size: 14pt"><B>SECURITIES AND EXCHANGE COMMISSION<BR>
WASHINGTON, D.C. 20549</B></DIV>



<HR noshade width="26%" align="center" size="1">

<DIV align="center" style="font-size: 14pt"><B>FORM S-8<BR>
REGISTRATION STATEMENT<BR>
UNDER<BR>
THE SECURITIES ACT OF 1933</B></DIV>


<HR noshade width="26%" align="center" size="1">

<DIV align="center" style="font-size: 14pt"><B>ALLERGAN, INC.</B></DIV>


<DIV align="center" style="font-size: 9pt">(Exact Name of Registrant as Specified in Its Charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="85%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Delaware</B><BR>
(State or Other Jurisdiction of<BR>
Incorporation or Organization)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>95-01622442</B><BR>
(I.R.S. Employer<BR>
Identification Number)</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt"><B>2525 Dupont Drive<BR>
Irvine, California 92612-1599</B></DIV>


<DIV align="center" style="font-size: 9pt">(Address of Principal Executive Offices including Zip Code)</DIV>


<HR noshade width="26%" align="center" size="1">

<DIV align="center" style="font-size: 14pt"><B>ALLERGAN, INC.<BR>
1989 INCENTIVE COMPENSATION PLAN, AS AMENDED</B></DIV>


<DIV align="center" style="font-size: 9pt">(Full Title of the Plan)</DIV>


<HR noshade width="26%" align="center" size="1">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="85%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Douglas S. Ingram, Esq.</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>Copy to:</B></TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><B>Executive Vice President, General<BR>
Counsel and Secretary</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>Cary K. Hyden, Esq.<BR>
Jonn R. Beeson, Esq.</B></TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><B>ALLERGAN, INC.<BR>
2525 Dupont Drive</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>LATHAM &#038; WATKINS LLP<BR>
650 Town Center Drive, Twentieth Floor</B></TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><B>Irvine, California 92612-1599<BR>
(714)&nbsp;246-4500</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>Costa Mesa, California 92626<BR>
(714)&nbsp;540-1235</B></TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 9pt">(Name and Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service)


<P>
<HR noshade width="26%" align="center" size="1">
<P>


<HR noshade size="1">


<DIV align="center" style="font-size: 10pt"><B>CALCULATION OF REGISTRATION FEE</B></DIV>

<HR noshade size="1">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR style="font-size: 8pt" valign="bottom">
    <TD width="34%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="8%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="12%" nowrap align="center" colspan="3"><B>Proposed</B></TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="12%" nowrap align="center" colspan="3"><B>&nbsp;</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Proposed</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Maximum</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>&nbsp;</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Amount</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Maximum</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Aggregate</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Amount of</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Title of Securities to be</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>to be</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Offering Price</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Offering</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Registration</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Registered</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Registered (1)(3)</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Per Share (2)</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Price (2)</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Fee</B></TD>
</TR>



<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" colspan="17"><HR noshade size="1"> </TD>
</TR>




<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">Common Stock, $0.01 par value</DIV></TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="center">16,000,000 shares</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="center">$73.34</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="center">$1,173,468,941</TD>
    <TD>&nbsp;</TD>
    <TD align="center" colspan="3">$148,679</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>

<HR noshade size="1">

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 9pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">(1)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Allergan, Inc. 1989 Incentive Compensation Plan, as amended and
restated (the &#147;Plan&#148;), authorizes the issuance of shares of common stock,
par value $0.01 per share, of Allergan, Inc. (the &#147;Company&#148;) (the &#147;Common
Stock&#148;), of which 16,000,000 shares are being registered hereunder and
30,361,629 of which have been previously registered.</TD>
</TR>


<TR valign="top" style="font-size: 9pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">(2)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Proposed Maximum Offering Price Per Share has been estimated solely
for the purpose of calculating the registration fee (i)&nbsp;pursuant to Rule
457(h) under the Securities Act of 1933, as amended (the &#147;Securities
Act&#148;), on the basis of the weighted average exercise price per share of
$71.32 for 4,279,369 shares of Common Stock subject to previously granted
options under the Plan and (ii)&nbsp;pursuant to Rule 457(c) under the
Securities Act for 11,720,631 shares of Common Stock available for future
grant based upon the average of the high and low prices of a share of the
Common Stock as reported on the New York Stock Exchange on
July&nbsp;29,
2004.</TD>
</TR>

<TR valign="top" style="font-size: 9pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">(3)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>In the event of a stock split, stock dividend, spin-off, or similar
transaction involving the Common Stock, the number of shares registered
hereby shall automatically be increased to cover the additional shares in
accordance with Rule 416(a) under the Securities Act. Each share of
Common Stock being registered hereunder, if issued prior to the
termination of the Company&#146;s Rights Agreement, dated as of January&nbsp;25,
2000, as amended, will include one preferred share purchase right. Prior
to the occurrence of certain events, the preferred share purchase rights
will not be exercisable or evidenced separately from the Common Stock.</TD>
</TR>

</TABLE>


<HR size="1" noshade color="#000000" style="margin-top: -2px">
<HR size="4" noshade color="#000000" style="margin-top: -10px">





<DIV align="center" style="font-size: 10pt"><B>Proposed sale to take place as soon after the effective date of the Registration Statement as shares are issued.</B></DIV>



<P align="center" style="font-size: 10pt">Total Pages 9<BR>
Exhibit&nbsp;Index on Page 6



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<!-- TOC -->
<A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>

<P><CENTER>
<TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
<TR>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="76%"></TD>
</TR>
<TR><TD colspan="9"><A HREF="#000">PART I</A></TD></TR>
<TR><TD colspan="9"><A HREF="#001">PART II</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#002">Item&nbsp;6. Indemnification of Directors and Officers</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#003">Item&nbsp;8. Exhibits</A></TD></TR>
<TR><TD colspan="9"><A HREF="#004">SIGNATURES</A></TD></TR>
<TR><TD colspan="9"><A HREF="#005">INDEX TO EXHIBITS</A></TD></TR>
<TR><TD colspan="9"><A HREF="a00730exv5w1.htm">EXHIBIT 5.1</A></TD></TR>
<TR><TD colspan="9"><A HREF="a00730exv23w2.htm">EXHIBIT 23.2</A></TD></TR>
</TABLE>
</CENTER>
<!-- /TOC -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>






<!-- link1 "PART I" -->
<DIV align="left"><A NAME="000"></A></DIV>

<P align="center" style="font-size: 10pt"><B>PART I</B>



<P align="center" style="font-size: 10pt"><B>INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The information called for in Part&nbsp;I of Form S-8 is not being filed with
or included in this Form S-8 (by incorporation by reference or otherwise) in
accordance with the rules and regulations of the Securities and Exchange
Commission (the &#147;Commission&#148;).

<!-- link1 "PART II" -->
<DIV align="left"><A NAME="001"></A></DIV>

<P align="center" style="font-size: 10pt"><B>PART II</B>



<P align="center" style="font-size: 10pt"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B>



<P align="left" style="font-size: 10pt"><B><U>Registration of Additional Securities</U></B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has previously registered 30,361,629 shares of the Common
Stock (after giving effect to stock splits, stock dividends, spin-offs and
similar transactions, as set forth in the Plan) issuable under the Plan by a
(i)&nbsp;Registration Statement on Form S-8 filed with the Commission on April&nbsp;25,
1997, Registration No.&nbsp;333-25891, (ii)&nbsp;Registration Statement on Form S-8 filed
with the Commission on June&nbsp;30, 1992, Registration No.&nbsp;333-48908, and (iii)
Registration Statement on Form S-8 filed with the Commission on June&nbsp;26, 1989,
Registration No.&nbsp;333-29527 (the &#147;Prior Registration Statements&#148;). Under this
Registration Statement, the Company is registering an additional 16,000,000
shares of Common Stock issuable under the Plan. The contents of the Prior
Registration Statements are incorporated by reference herein to the extent not
modified or superseded hereby or by any subsequently filed document that is
incorporated by reference herein or therein.


<P align="left" style="font-size: 10pt"><B><U>Experts</U></B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The consolidated financial statements and schedule of Allergan, Inc. and
subsidiaries as of December&nbsp;31, 2003 and 2002, and for each of the years in the
three-year period ended December&nbsp;31, 2003, have been incorporated by reference
herein in reliance upon the reports of KPMG LLP, independent registered public
accounting firm, incorporated by reference herein, and upon the authority of
said firm as experts in accounting and auditing. The audit reports refer to a
change in the method of accounting for derivative instruments and hedging
activities in 2001 and a change in the method of accounting for goodwill and
intangible assets in 2002.

<!-- link2 "Item&nbsp;6. Indemnification of Directors and Officers" -->
<DIV align="left"><A NAME="002"></A></DIV>

<P align="left" style="font-size: 10pt"><B>Item&nbsp;6. <U>Indemnification of Directors and Officers</U></B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;145(a) of the General Corporation Law of the State of Delaware
(the &#147;DGCL&#148;) provides that a Delaware corporation may indemnify any person who
was or is a party or is threatened to be made a party to any threatened,
pending or completed action, suit or proceeding, whether civil, criminal,
administrative or investigative (other than an action by or in the right of the
corporation) by reason of the fact that such person is or was a director,
officer, employee or agent of the corporation or is or was serving at the
request of the corporation as a director, officer, employee or agent of another
corporation or enterprise, against expenses, judgments, fines and amounts paid
in settlement actually and reasonably incurred by such person in connection
with such action, suit or proceeding if he acted in good faith and in a manner
he reasonably believed to be in or not opposed to the best interests of the
corporation, and, with respect to any criminal action or proceeding, had no
cause to believe his conduct was unlawful.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;145(b) of the DGCL provides that a Delaware corporation may
indemnify any person who was or is a party or is threatened to be made a party
to any threatened, pending or completed action or suit by or in the right of
the corporation to procure a judgment in its favor by reason of the fact that
such person acted in any of the capacities set forth above, against expenses
actually and reasonably incurred by such person in connection with the defense
or settlement of such action or suit if he or she acted under similar standards
to those set forth above, except that no indemnification may be made with
respect to any claim, issue or matter as to which such person shall have been
adjudged to be liable to the corporation unless and only to the extent that the
court in which such action or suit was brought shall determine that despite the
adjudication of liability, but in view of all the circumstances of the case,
such person is fairly and reasonably entitled to be indemnified for such
expenses which the court shall deem proper.


<P align="center" style="font-size: 10pt">2
</DIV>


<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<P align="left" style="font-size: 10pt">Section&nbsp;145 of the DGCL further provides that to the extent a director or
officer of a corporation has been successful in the defense of any action, suit
or proceeding referred to in subsection (a)&nbsp;and (b)&nbsp;or in the defense of any
claim, issue or matter therein, he shall be indemnified against expenses
actually and reasonably incurred by him in connection therewith; that
indemnification provided for by Section&nbsp;145 of the DGCL shall not be deemed
exclusive of any other rights to which the indemnified party may be entitled;
and that the corporation may purchase and maintain insurance on behalf of a
director or officer of the corporation against any liability asserted against
such officer or director and incurred by him or her in any such capacity or
arising out of his or her status as such, whether or not the corporation would
have the power to indemnify him or her against such liabilities under Section
145 of the DGCL.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As permitted by Section&nbsp;102(b)(7) of the DGCL, the Company&#146;s Certificate
of Incorporation, as amended, provides that a director shall not be liable to
the Company or its stockholders for monetary damages for breach of fiduciary
duty as a director. However, this provision does not eliminate or limit the
liability of a director for acts or omissions not in good faith or for
breaching his or her duty of loyalty, engaging in intentional misconduct or
knowingly violating the law, paying a dividend or approving a stock repurchase
which was illegal, or obtaining an improper personal benefit. A provision of
this type has no effect on the availability of equitable remedies, such as
injunction or rescission, for breach of fiduciary duty. The Company&#146;s
Certificate of Incorporation, as amended, requires that directors and officers
be indemnified to the maximum extent permitted by Delaware law.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has entered into indemnity agreements with each of its
directors and executive officers. These indemnity agreements require that the
Company pay on behalf of each director and executive officer party thereto any
amount that he or she is or becomes legally obligated to pay because of any
claim or claims made against him or her because of any act or omission or
neglect or breach of duty, including any actual or alleged error or
misstatement or misleading statement, which he or she commits or suffers while
acting in his or her capacity as a director and/or executive officer of the
Company and solely because of his or her being a director and/or executive
officer of the Company. Under the DGCL, absent such an indemnity agreement,
indemnification of a director or officer is discretionary rather than mandatory
(except in the case of a proceeding in which a director or officer is
successful on the merits). Consistent with the Company&#146;s Bylaw provision on the
subject, the indemnity agreements require the Company to make prompt payment of
defense and investigation costs and expenses at the request of the director or
executive officer in advance of indemnification, provided that the recipient
undertakes to repay the amounts if it is ultimately determined that he or she
is not entitled to indemnification for such expense and provided further that
such advance shall not be made if it is determined that the director or
executive officer acted in bad faith or deliberately breached his or her duty
to the Company or its stockholders and, as a result, it is more likely than not
that it will ultimately be determined that he or she is not entitled to
indemnification under the terms of the indemnity agreement. The indemnity
agreements make the advance of litigation expenses mandatory absent a special
determination to the contrary, whereas under the DGCL absent such an indemnity
agreement, such advance would be discretionary. Under the indemnity agreements,
the Company would not be required to pay or reimburse the director or executive
officer for his or her expenses in seeking indemnification recovery against the
Company. By the terms of the indemnity agreements, benefits are not available
if the director or executive officer has received payment from one or more
insurance policies for the subject claim or, with respect to the matters giving
rise to the claim: (i)&nbsp;received a personal benefit; (ii)&nbsp;violated Section
16(b) of the Securities Exchange Act of 1934, as amended, or analogous
provisions of law; or (iii)&nbsp;committed certain acts of dishonesty. Absent the
indemnity agreements, indemnification that might be made available to directors
and officers could be changed by further amendments to the Company&#146;s
Certificate of Incorporation or Bylaws.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has a policy of directors&#146; liability insurance that insures
the directors and officers against the cost of defense, settlement or payment
of a judgment under certain circumstances.

<!-- link2 "Item&nbsp;8. Exhibits" -->
<DIV align="left"><A NAME="003"></A></DIV>

<P align="left" style="font-size: 10pt"><B>Item&nbsp;8. <U>Exhibits</U></B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See Index to Exhibits on page 6.


<P align="center" style="font-size: 10pt">3
</DIV>


<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- link1 "SIGNATURES" -->
<DIV align="left"><A NAME="004"></A></DIV>

<P align="center" style="font-size: 10pt"><B>SIGNATURES</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, the Company
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Irvine, State of California, on this 3rd day of
August, 2004.


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top">&nbsp;</TD>
    <TD colspan="3"><B>ALLERGAN, INC.</B><BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD>&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000">/s/ DAVID E.I. PYOTT</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2">David E.I. Pyott, &nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2">Chairman of the
Board, President and Chief Executive
Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top">&nbsp;</TD>
    <TD colspan="3">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD>&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000">
/s/ ERIC K. BRANDT</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2">Eric K. Brandt, &nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2">Executive Vice President, Finance, Strategy and Corporate Development&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt"><B>POWER OF ATTORNEY</B>




<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each person whose signature appears below hereby authorizes and appoints
each of David E.I. Pyott, Eric K. Brandt, Douglas S. Ingram and Matthew J.
Maletta, as attorney-in-fact and agent, each acting alone, with full power of
substitution and resubstitution, to sign on his or her behalf, individually and
in the capacities stated below, and to file any and all amendments, including
post-effective amendments, to this registration statement and other documents
in connection therewith, with the Securities and Exchange Commission, granting
to said attorney-in-fact and agent full power and authority to perform any
other act on behalf of the undersigned required to be done in the premises.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons in the
capacities indicated as of the 3rd day of August, 2004.

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center"><B>Signature</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Title</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" nowrap valign="top"><DIV style="margin-left:0px; text-indent:-0px"><BR></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ DAVID E.I. PYOTT<BR>
<HR size="1" noshade>
David E.I. Pyott</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Chairman of the Board, President and Chief Executive Officer (Principal Executive Officer)</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top"><BR></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ ERIC K. BRANDT<BR>
<HR size="1" noshade>
Eric K. Brandt</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Executive Vice President, Finance, Strategy and Corporate Development (Principal Financial Officer)</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top"><BR></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ JAMES F. BARLOW<BR>
<HR size="1" noshade>
James F. Barlow</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Vice President, Corporate Controller (Principal Accounting Officer)</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top"><BR></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ HERBERT W. BOYER<BR>
<HR size="1" noshade>
Herbert W. Boyer, Ph.D.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Vice Chairman of the Board</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">4
</DIV>


<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center"><B>Signature</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Title</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top"><BR></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ HANDEL E. EVANS<BR>
<HR size="1" noshade>
Handel E. Evans</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top"><BR></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ MICHAEL R. GALLAGHER<BR>
<HR size="1" noshade>
Michael R. Gallagher</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top"><BR></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ GAVIN S. HERBERT<BR>
<HR size="1" noshade>
Gavin S. Herbert</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top"><BR></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ TREVOR M. JONES<BR>
<HR size="1" noshade>
Trevor M. Jones, Ph.D.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top"><BR></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ KAREN R. OSAR<BR>
<HR size="1" noshade>
Karen R. Osar</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top"><BR></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ RUSSELL T. RAY<BR>
<HR size="1" noshade>
Russell T. Ray</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top"><BR></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ LOUIS T. ROSSO<BR>
<HR size="1" noshade>
Louis T. Rosso</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top"><BR></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ STEPHEN J. RYAN<BR>
<HR size="1" noshade>
Stephen J. Ryan, M.D.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top"><BR></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ LEONARD D. SCHAEFFER<BR>
<HR size="1" noshade>
Leonard D. Schaeffer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">5
</DIV>


<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- link1 "INDEX TO EXHIBITS" -->
<DIV align="left"><A NAME="005"></A></DIV>

<P align="center" style="font-size: 10pt"><B>INDEX TO EXHIBITS</B>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="90%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="44%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>EXHIBIT</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>PAGE NO.</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Certificate of Designations of Series&nbsp;A Junior Participating Preferred Stock as
filed with the State of Delaware on February&nbsp;1, 2000 (incorporated by reference
to Exhibit&nbsp;4.1 to the Company&#146;s Report on Form&nbsp;10-K for the Fiscal Year ended
December&nbsp;31, 1999)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px"><BR></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Rights Agreement, dated January&nbsp;25, 2000, between the Company and First Chicago
Trust Company of New York (&#147;Rights Agreement&#148;) (incorporated by reference to
Exhibit&nbsp;4 to the Company&#146;s Current Report on Form&nbsp;8-K filed on January&nbsp;28, 2000)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px"><BR></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.3
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amendment to Rights Agreement dated as of January&nbsp;2, 2002 between First Chicago
Trust Company of New York, the Company and EquiServe Trust Company, N.A., as
successor Rights Agent (incorporated by reference to Exhibit&nbsp;4.3 of the
Company&#146;s Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2001)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px"><BR></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.4
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Second Amendment to Rights Agreement dated as of January&nbsp;30, 2003 between First
Chicago Trust Company of New York, the Company and EquiServe Trust Company,
N.A., as successor Rights Agent (incorporated by reference to Exhibit&nbsp;1 of the
Company&#146;s amended Form&nbsp;8-A filed on February&nbsp;14, 2003)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px"><BR></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.5
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Indenture between the Company and BankAmerica National Trust Company
(incorporated by reference to Exhibit&nbsp;4 filed with the Company&#146;s Registration
Statement 33-69746)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px"><BR></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.6
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Indenture, dated as of November&nbsp;1, 2000, between the Company and U.S. Trust
National Association (incorporated by reference to Exhibit&nbsp;4.1 to the Company&#146;s
Current Report on Form&nbsp;8-K, filed on November&nbsp;1, 2000)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px"><BR></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.7
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Registration Rights Agreement, dated November&nbsp;1, 2000, between the Company and
Merrill Lynch &#038; Co., Merrill Lynch, Pierce Fenner &#038; Smith Incorporated
(incorporated by reference to Exhibit&nbsp;4.2 to the Company&#146;s Current Report on
Form&nbsp;8-K, filed on November&nbsp;1, 2000)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px"><BR></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.8
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Indenture, dated as of November&nbsp;6, 2002, between the Company and Wells Fargo
Bank National Association (incorporated by reference to Exhibit&nbsp;4.1 filed with
the Company&#146;s Registration Statement 333-102425)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px"><BR></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.9
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form of Zero Coupon Convertible Senior Note Due 2022 (incorporated by reference
to Exhibit&nbsp;4.2 filed with the Company&#146;s Registration Statement 333-102425)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px"><BR></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.10
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Registration Rights Agreement dated as of November&nbsp;6, 2002, by and between the
Company and Banc of America Securities LLC, Salomon Smith Barney Inc., J.P.
Morgan Securities Inc. and Banc One Capital Markets, Inc. (incorporated by
reference to Exhibit&nbsp;4.3 filed with the Company&#146;s Registration Statement
333-102425)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px"><BR></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">5.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Opinion of Counsel
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">7</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px"><BR></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Counsel (included in Exhibit&nbsp;5.1)
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">7</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px"><BR></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of KPMG LLP
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">9</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px"><BR></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">24
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Power of Attorney (included in the signature page to this Registration Statement)
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">6
</DIV>

</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "a00730sv8.htm", "description": "FORM S-8", "secsgml_size_bytes": 45743}]
{"company-data": {"conformed-name": "ALLERGAN INC", "cik": "0000850693", "assigned-sic": "2834", "irs-number": "951622442", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-117935", "film-number": "04952536"}, "business-address": {"street1": "2525 DUPONT DRIVE", "city": "IRVINE", "state": "CA", "zip": "92612", "phone": "7142464500"}, "mail-address": {"street1": "P.O. BOX 19534", "city": "IRVINE", "state": "CA", "zip": "92713-9534"}}
sv8
Table of Contents
As filed with the
Securities and Exchange Commission on August 4, 2004
Registration No. 333-
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
ALLERGAN, INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or Other Jurisdiction of
Incorporation or Organization)
95-01622442
(I.R.S. Employer
Identification Number)
2525 Dupont Drive
Irvine, California 92612-1599
(Address of Principal Executive Offices including Zip Code)
ALLERGAN, INC.
1989 INCENTIVE COMPENSATION PLAN, AS AMENDED
(Full Title of the Plan)
Douglas S. Ingram, Esq.
Copy to:
Executive Vice President, General
Counsel and Secretary
Cary K. Hyden, Esq.
Jonn R. Beeson, Esq.
ALLERGAN, INC.
2525 Dupont Drive
LATHAM & WATKINS LLP
650 Town Center Drive, Twentieth Floor
Irvine, California 92612-1599
(714) 246-4500
Costa Mesa, California 92626
(714) 540-1235
(Name and Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service)
CALCULATION OF REGISTRATION FEE
Proposed
Proposed
Maximum
Amount
Maximum
Aggregate
Amount of
Title of Securities to be
to be
Offering Price
Offering
Registration
Registered
Registered (1)(3)
Per Share (2)
Price (2)
Fee
Common Stock, $0.01 par value
16,000,000 shares
$73.34
$1,173,468,941
$148,679
(1)
The Allergan, Inc. 1989 Incentive Compensation Plan, as amended and
restated (the "Plan"), authorizes the issuance of shares of common stock,
par value $0.01 per share, of Allergan, Inc. (the "Company") (the "Common
Stock"), of which 16,000,000 shares are being registered hereunder and
30,361,629 of which have been previously registered.
(2)
The Proposed Maximum Offering Price Per Share has been estimated solely
for the purpose of calculating the registration fee (i) pursuant to Rule
457(h) under the Securities Act of 1933, as amended (the "Securities
Act"), on the basis of the weighted average exercise price per share of
$71.32 for 4,279,369 shares of Common Stock subject to previously granted
options under the Plan and (ii) pursuant to Rule 457(c) under the
Securities Act for 11,720,631 shares of Common Stock available for future
grant based upon the average of the high and low prices of a share of the
Common Stock as reported on the New York Stock Exchange on
July 29,
2004.
(3)
In the event of a stock split, stock dividend, spin-off, or similar
transaction involving the Common Stock, the number of shares registered
hereby shall automatically be increased to cover the additional shares in
accordance with Rule 416(a) under the Securities Act. Each share of
Common Stock being registered hereunder, if issued prior to the
termination of the Company's Rights Agreement, dated as of January 25,
2000, as amended, will include one preferred share purchase right. Prior
to the occurrence of certain events, the preferred share purchase rights
will not be exercisable or evidenced separately from the Common Stock.
Proposed sale to take place as soon after the effective date of the Registration Statement as shares are issued.
Total Pages 9
Exhibit Index on Page 6
TABLE OF CONTENTS
PART I
PART II
Item 6. Indemnification of Directors and Officers
Item 8. Exhibits
SIGNATURES
INDEX TO EXHIBITS
EXHIBIT 5.1
EXHIBIT 23.2
Table of Contents
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
The information called for in Part I of Form S-8 is not being filed with
or included in this Form S-8 (by incorporation by reference or otherwise) in
accordance with the rules and regulations of the Securities and Exchange
Commission (the "Commission").
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Registration of Additional Securities
The Company has previously registered 30,361,629 shares of the Common
Stock (after giving effect to stock splits, stock dividends, spin-offs and
similar transactions, as set forth in the Plan) issuable under the Plan by a
(i) Registration Statement on Form S-8 filed with the Commission on April 25,
1997, Registration No. 333-25891, (ii) Registration Statement on Form S-8 filed
with the Commission on June 30, 1992, Registration No. 333-48908, and (iii)
Registration Statement on Form S-8 filed with the Commission on June 26, 1989,
Registration No. 333-29527 (the "Prior Registration Statements"). Under this
Registration Statement, the Company is registering an additional 16,000,000
shares of Common Stock issuable under the Plan. The contents of the Prior
Registration Statements are incorporated by reference herein to the extent not
modified or superseded hereby or by any subsequently filed document that is
incorporated by reference herein or therein.
Experts
The consolidated financial statements and schedule of Allergan, Inc. and
subsidiaries as of December 31, 2003 and 2002, and for each of the years in the
three-year period ended December 31, 2003, have been incorporated by reference
herein in reliance upon the reports of KPMG LLP, independent registered public
accounting firm, incorporated by reference herein, and upon the authority of
said firm as experts in accounting and auditing. The audit reports refer to a
change in the method of accounting for derivative instruments and hedging
activities in 2001 and a change in the method of accounting for goodwill and
intangible assets in 2002.
Item 6.
Indemnification of Directors and Officers
Section 145(a) of the General Corporation Law of the State of Delaware
(the "DGCL") provides that a Delaware corporation may indemnify any person who
was or is a party or is threatened to be made a party to any threatened,
pending or completed action, suit or proceeding, whether civil, criminal,
administrative or investigative (other than an action by or in the right of the
corporation) by reason of the fact that such person is or was a director,
officer, employee or agent of the corporation or is or was serving at the
request of the corporation as a director, officer, employee or agent of another
corporation or enterprise, against expenses, judgments, fines and amounts paid
in settlement actually and reasonably incurred by such person in connection
with such action, suit or proceeding if he acted in good faith and in a manner
he reasonably believed to be in or not opposed to the best interests of the
corporation, and, with respect to any criminal action or proceeding, had no
cause to believe his conduct was unlawful.
Section 145(b) of the DGCL provides that a Delaware corporation may
indemnify any person who was or is a party or is threatened to be made a party
to any threatened, pending or completed action or suit by or in the right of
the corporation to procure a judgment in its favor by reason of the fact that
such person acted in any of the capacities set forth above, against expenses
actually and reasonably incurred by such person in connection with the defense
or settlement of such action or suit if he or she acted under similar standards
to those set forth above, except that no indemnification may be made with
respect to any claim, issue or matter as to which such person shall have been
adjudged to be liable to the corporation unless and only to the extent that the
court in which such action or suit was brought shall determine that despite the
adjudication of liability, but in view of all the circumstances of the case,
such person is fairly and reasonably entitled to be indemnified for such
expenses which the court shall deem proper.
2
Table of Contents
Section 145 of the DGCL further provides that to the extent a director or
officer of a corporation has been successful in the defense of any action, suit
or proceeding referred to in subsection (a) and (b) or in the defense of any
claim, issue or matter therein, he shall be indemnified against expenses
actually and reasonably incurred by him in connection therewith; that
indemnification provided for by Section 145 of the DGCL shall not be deemed
exclusive of any other rights to which the indemnified party may be entitled;
and that the corporation may purchase and maintain insurance on behalf of a
director or officer of the corporation against any liability asserted against
such officer or director and incurred by him or her in any such capacity or
arising out of his or her status as such, whether or not the corporation would
have the power to indemnify him or her against such liabilities under Section
145 of the DGCL.
As permitted by Section 102(b)(7) of the DGCL, the Company's Certificate
of Incorporation, as amended, provides that a director shall not be liable to
the Company or its stockholders for monetary damages for breach of fiduciary
duty as a director. However, this provision does not eliminate or limit the
liability of a director for acts or omissions not in good faith or for
breaching his or her duty of loyalty, engaging in intentional misconduct or
knowingly violating the law, paying a dividend or approving a stock repurchase
which was illegal, or obtaining an improper personal benefit. A provision of
this type has no effect on the availability of equitable remedies, such as
injunction or rescission, for breach of fiduciary duty. The Company's
Certificate of Incorporation, as amended, requires that directors and officers
be indemnified to the maximum extent permitted by Delaware law.
The Company has entered into indemnity agreements with each of its
directors and executive officers. These indemnity agreements require that the
Company pay on behalf of each director and executive officer party thereto any
amount that he or she is or becomes legally obligated to pay because of any
claim or claims made against him or her because of any act or omission or
neglect or breach of duty, including any actual or alleged error or
misstatement or misleading statement, which he or she commits or suffers while
acting in his or her capacity as a director and/or executive officer of the
Company and solely because of his or her being a director and/or executive
officer of the Company. Under the DGCL, absent such an indemnity agreement,
indemnification of a director or officer is discretionary rather than mandatory
(except in the case of a proceeding in which a director or officer is
successful on the merits). Consistent with the Company's Bylaw provision on the
subject, the indemnity agreements require the Company to make prompt payment of
defense and investigation costs and expenses at the request of the director or
executive officer in advance of indemnification, provided that the recipient
undertakes to repay the amounts if it is ultimately determined that he or she
is not entitled to indemnification for such expense and provided further that
such advance shall not be made if it is determined that the director or
executive officer acted in bad faith or deliberately breached his or her duty
to the Company or its stockholders and, as a result, it is more likely than not
that it will ultimately be determined that he or she is not entitled to
indemnification under the terms of the indemnity agreement. The indemnity
agreements make the advance of litigation expenses mandatory absent a special
determination to the contrary, whereas under the DGCL absent such an indemnity
agreement, such advance would be discretionary. Under the indemnity agreements,
the Company would not be required to pay or reimburse the director or executive
officer for his or her expenses in seeking indemnification recovery against the
Company. By the terms of the indemnity agreements, benefits are not available
if the director or executive officer has received payment from one or more
insurance policies for the subject claim or, with respect to the matters giving
rise to the claim: (i) received a personal benefit; (ii) violated Section
16(b) of the Securities Exchange Act of 1934, as amended, or analogous
provisions of law; or (iii) committed certain acts of dishonesty. Absent the
indemnity agreements, indemnification that might be made available to directors
and officers could be changed by further amendments to the Company's
Certificate of Incorporation or Bylaws.
The Company has a policy of directors' liability insurance that insures
the directors and officers against the cost of defense, settlement or payment
of a judgment under certain circumstances.
Item 8.
Exhibits
See Index to Exhibits on page 6.
3
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Company
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Irvine, State of California, on this 3rd day of
August, 2004.
ALLERGAN, INC.
By:
/s/ DAVID E.I. PYOTT
David E.I. Pyott,
Chairman of the
Board, President and Chief Executive
Officer
By:
/s/ ERIC K. BRANDT
Eric K. Brandt,
Executive Vice President, Finance, Strategy and Corporate Development
POWER OF ATTORNEY
Each person whose signature appears below hereby authorizes and appoints
each of David E.I. Pyott, Eric K. Brandt, Douglas S. Ingram and Matthew J.
Maletta, as attorney-in-fact and agent, each acting alone, with full power of
substitution and resubstitution, to sign on his or her behalf, individually and
in the capacities stated below, and to file any and all amendments, including
post-effective amendments, to this registration statement and other documents
in connection therewith, with the Securities and Exchange Commission, granting
to said attorney-in-fact and agent full power and authority to perform any
other act on behalf of the undersigned required to be done in the premises.
Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons in the
capacities indicated as of the 3rd day of August, 2004.
Signature
Title
/s/ DAVID E.I. PYOTT
David E.I. Pyott
Chairman of the Board, President and Chief Executive Officer (Principal Executive Officer)
/s/ ERIC K. BRANDT
Eric K. Brandt
Executive Vice President, Finance, Strategy and Corporate Development (Principal Financial Officer)
/s/ JAMES F. BARLOW
James F. Barlow
Vice President, Corporate Controller (Principal Accounting Officer)
/s/ HERBERT W. BOYER
Herbert W. Boyer, Ph.D.
Vice Chairman of the Board
4
Table of Contents
Signature
Title
/s/ HANDEL E. EVANS
Handel E. Evans
Director
/s/ MICHAEL R. GALLAGHER
Michael R. Gallagher
Director
/s/ GAVIN S. HERBERT
Gavin S. Herbert
Director
/s/ TREVOR M. JONES
Trevor M. Jones, Ph.D.
Director
/s/ KAREN R. OSAR
Karen R. Osar
Director
/s/ RUSSELL T. RAY
Russell T. Ray
Director
/s/ LOUIS T. ROSSO
Louis T. Rosso
Director
/s/ STEPHEN J. RYAN
Stephen J. Ryan, M.D.
Director
/s/ LEONARD D. SCHAEFFER
Leonard D. Schaeffer
Director
5
Table of Contents
INDEX TO EXHIBITS
EXHIBIT
PAGE NO.
4.1
Certificate of Designations of Series A Junior Participating Preferred Stock as
filed with the State of Delaware on February 1, 2000 (incorporated by reference
to Exhibit 4.1 to the Company's Report on Form 10-K for the Fiscal Year ended
December 31, 1999)
4.2
Rights Agreement, dated January 25, 2000, between the Company and First Chicago
Trust Company of New York ("Rights Agreement") (incorporated by reference to
Exhibit 4 to the Company's Current Report on Form 8-K filed on January 28, 2000)
4.3
Amendment to Rights Agreement dated as of January 2, 2002 between First Chicago
Trust Company of New York, the Company and EquiServe Trust Company, N.A., as
successor Rights Agent (incorporated by reference to Exhibit 4.3 of the
Company's Annual Report on Form 10-K for the year ended December 31, 2001)
4.4
Second Amendment to Rights Agreement dated as of January 30, 2003 between First
Chicago Trust Company of New York, the Company and EquiServe Trust Company,
N.A., as successor Rights Agent (incorporated by reference to Exhibit 1 of the
Company's amended Form 8-A filed on February 14, 2003)
4.5
Indenture between the Company and BankAmerica National Trust Company
(incorporated by reference to Exhibit 4 filed with the Company's Registration
Statement 33-69746)
4.6
Indenture, dated as of November 1, 2000, between the Company and U.S. Trust
National Association (incorporated by reference to Exhibit 4.1 to the Company's
Current Report on Form 8-K, filed on November 1, 2000)
4.7
Registration Rights Agreement, dated November 1, 2000, between the Company and
Merrill Lynch & Co., Merrill Lynch, Pierce Fenner & Smith Incorporated
(incorporated by reference to Exhibit 4.2 to the Company's Current Report on
Form 8-K, filed on November 1, 2000)
4.8
Indenture, dated as of November 6, 2002, between the Company and Wells Fargo
Bank National Association (incorporated by reference to Exhibit 4.1 filed with
the Company's Registration Statement 333-102425)
4.9
Form of Zero Coupon Convertible Senior Note Due 2022 (incorporated by reference
to Exhibit 4.2 filed with the Company's Registration Statement 333-102425)
4.10
Registration Rights Agreement dated as of November 6, 2002, by and between the
Company and Banc of America Securities LLC, Salomon Smith Barney Inc., J.P.
Morgan Securities Inc. and Banc One Capital Markets, Inc. (incorporated by
reference to Exhibit 4.3 filed with the Company's Registration Statement
333-102425)
5.1
Opinion of Counsel
7
23.1
Consent of Counsel (included in Exhibit 5.1)
7
23.2
Consent of KPMG LLP
9
24
Power of Attorney (included in the signature page to this Registration Statement)
4
6